We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+14.45%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.5B
AUM Growth
+$6.37B
(+17%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
9.32%
Holding
3,484
New
550
Increased
1,237
Reduced
1,116
Closed
366
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
801
DELISTED
QVC Group Inc Series A
QVCGA
| $6.8M | 0.02% |
155,343
-1,602
| -1% | -$54.9K |
|
802
F5
FFIV
$21.7B
| $6.76M | 0.02% |
37,793
-114,684
| -75% | -$18.7M |
|
|
VMEO
803
DELISTED
Vimeo
VMEO
| $6.75M | 0.02% |
1,721,461
-285,854
| -14% | -$1.02M |
|
804
Invesco Mortgage Capital
IVR
$801M
| $6.74M | 0.02% |
760,605
+479,329
| +170% | +$3.91M |
|
805
GlobalFoundries
GFS
$25.2B
| $6.73M | 0.02% |
111,064
-204,910
| -65% | -$11.4M |
|
806
Barings BDC
BBDC
$989M
| $6.71M | 0.02% |
782,620
-92,588
| -11% | -$824K |
|
807
Ironwood Pharmaceuticals
IRWD
$725M
| $6.7M | 0.02% |
585,847
-808,316
| -58% | -$8M |
|
808
Jazz Pharmaceuticals
JAZZ
$16.9B
| $6.7M | 0.02% |
54,481
+18,981
| +53% | +$2.37M |
|
809
Cipher Digital
CIFR
$6.77B
| $6.69M | 0.02% |
1,620,251
+1,569,434
| +3,088% | +$4.78M |
|
810
Nu Skin
NUS
$236M
| $6.66M | 0.02% |
342,695
-393
| -0.1% | -$7.25K |
|
|
SNBR
811
DELISTED
Sleep Number
SNBR
| $6.64M | 0.02% |
447,710
+418,380
| +1,426% | +$6.49M |
|
|
MZTI
812
The Marzetti Company
MZTI
$3.22B
| $6.62M | 0.02% |
39,761
+12,161
| +44% | +$2.04M |
|
813
Hercules Capital
HTGC
$3.29B
| $6.59M | 0.02% |
395,353
-98,838
| -20% | -$1.56M |
|
|
DCPH
814
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.58M | 0.02% |
407,932
+378,226
| +1,273% | +$4.82M |
|
|
SWI
815
DELISTED
SolarWinds Corporation Common Stock
SWI
| $6.56M | 0.02% |
525,032
+172,738
| +49% | +$1.86M |
|
816
Sanmina
SANM
$10.2B
| $6.54M | 0.02% |
127,333
+72,552
| +132% | +$3.7M |
|
|
CGAU
817
Centerra Gold
CGAU
$4.73B
| $6.49M | 0.01% |
1,088,562
+433,261
| +66% | +$2.37M |
|
818
Dine Brands
DIN
$449M
| $6.49M | 0.01% |
130,634
-7,918
| -6% | -$376K |
|
819
Beazer Homes USA
BZH
$885M
| $6.46M | 0.01% |
191,129
-106,724
| -36% | -$2.92M |
|
|
DCBO
820
Docebo
DCBO
$614M
| $6.44M | 0.01% |
133,177
+54,095
| +68% | +$2.41M |
|
821
Open Text
OTEX
$5.9B
| $6.42M | 0.01% |
152,777
+115,677
| +312% | +$4.34M |
|
822
Marcus Corp
MCS
$930M
| $6.4M | 0.01% |
439,184
+158,772
| +57% | +$2.38M |
|
823
Teekay
TK
$1.17B
| $6.4M | 0.01% |
895,480
+18,898
| +2% | +$130K |
|
|
TGH
824
DELISTED
Textainer Group Holdings limited
TGH
| $6.39M | 0.01% |
129,923
-90,066
| -41% | -$4.15M |
|
|
DMC
825
Del Monte Corp
DMC
$1.5B
| $6.37M | 0.01% |
242,507
+50,075
| +26% | +$1.23M |
|
Similar funds
John Overdeck's Q4 2023 Portfolio in Review
As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- John Overdeck opened 550 new positions and closed 366 in Q4 2023.
- John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.